Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme

Jan Karl Burkhardt, Benjamin J. Shin, Cody D. Schlaff, Howard Riina, John A. Boockvar

Research output: Contribution to journalArticle

7 Scopus citations

Fingerprint Dive into the research topics of 'Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme'. Together they form a unique fingerprint.

Medicine & Life Sciences